ATRCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
AtriCure, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 27, 2026
$55.53−0.54 (-0.96%)
Close on Oct 19, 2026
- Market cap
- $2.71B
- P/E (TTM)
- 264.4
- Dividend yield
- –
AtriCure, Inc. revenue by segment
By business segment
By product or service
By region
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $125.59M | $116.21M | $114.33M | $109.31M | $110.58M | $101.15M | $101.58M | $95.45M | $95.54M | $90.25M | $88.76M | $81.69M | 81.8% | +13.6% |
| Total International | $28.02M | $25.04M | $26.17M | $24.96M | $25.56M | $22.47M | $22.70M | $20.46M | $20.73M | $18.60M | $17.78M | $16.60M | 18.2% | +9.6% |
| Europe | $17.21M | $16.07M | $15.99M | $15.17M | $16.13M | $14.20M | $13.68M | $12.22M | $12.63M | $11.35M | $10.39M | $9.22M | 11.2% | +6.7% |
| Asia Pacific | $8.63M | $7.08M | – | – | $7.48M | $6.78M | – | – | – | – | – | – | 5.6% | +15.4% |
| Other International | $2.17M | $1.89M | $1.80M | $1.71M | $1.94M | $1.49M | $1.56M | $1.33M | $1.38M | $973.00K | $958.00K | $813.00K | 1.4% | +12.1% |
| Asia Pacific | – | – | – | $8.08M | $7.48M | $6.78M | – | $6.91M | $6.72M | $6.28M | – | $6.57M | – | – |
From the segment and revenue-disaggregation notes of AtriCure's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.